Last week, President Donald Trump warned that acetaminophen, the active ingredient in Tylenol, is a potential cause of autism. Many medical professionals say the relationship between acetaminophen and autism is inconclusive, and Trump's comments went beyond what his own administration officials recommend. Still, the press conference caused a crisis at the company that makes Tylenol, Kenvue. WSJ’s Peter Loftus on Kenvue CEO Kirk Perry’s attempts to manage the Trump Administration and the new corporate crisis. Jessica Mendoza hosts.

Further Listening:

- The FDA Commissioner on Vaccines and Public Trust

- Why Coke Isn’t Getting Rid of High-Fructose Corn Syrup

Sign up for WSJ’s free What’s News newsletter.

Learn more about your ad choices. Visit megaphone.fm/adchoices